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Hepatitis B virus infection is an infectious disease caused by the Hepatitis B virus which is a global problem. It is 
estimated that more than 240 million people have been infected and every 620,000 people die from hepatitis B infection 
every year. Pregnant women range from Hepatitis B infection, can result in an increased risk of preterm birth, low birth 
weight (<2500 g), premature rupture of membranes, gestational diabetes, congenital abnormalities. Other consequences 
are miscarriage, liver damage, acute Hepatitis, or chronic, hepatocellular carcinoma. This   aims of this study was 
determine the incidence of reactive pregnant women from the rapid test of HBsAg. Methods: This study was  a 
descriptive observational study, by collecting data from the 2018 HBsAg examination sheet. The data sheet is the result 
of routine HBsAg examination in pregnant women Binanga Health Center, Mamuju Regency. . The independent 
variables identified were characteristic and sociodemographic data. Descriptive statistical tests were carried out in the 
form of frequency, percentage. The number of pregnant women who were reactive to HBsAg was 13 (2%) of 647 
pregnant women throughout 2018, among those who were reactive were aged 20-30 years. However, pregnant women 
who are reactive to HBsAg are around the age of 20-30 years. The prevalence of reactive HBsAg in pregnant women in 
the Binanga Community Health Center is 13(2%).  
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ABSTRAK   
Infeksi virus Hepatitis B adalah   penyakit infeksi yang disebabkan oleh virus Hepatitis B yang menjadi masalah global.  
Diperkirakan lebih 240 juta jiwa telah terinfeksi dan setiap 620.000 jiwa meninggal akibat infeksi Hepatitis B setiap 
tahun. Wanita hamil rentang dari infeksi Hepatitis B,  dapat  menghasilkan  peningkatan risiko kelahiran prematur, berat 
lahir rendah (<2500 g), ketuban pecah dini,  diabetes gestasional, kelainan bawaan. Akibat lain adalah  keguguran,  
kerusakan hati,   Hepatitis akut,   atau kronis,   karsinoma hepatoseluler. Tujuan: penelitian ini bertujuan untuk 
mengetahui   tingkat  kejadian ibu hamil yang reaktif   dari pemeriksaan rapid  test HBsAg. Metode: Penelitian ini 
merupakan observasional deskriptif,    dengan mengumpulkan data dari lembar pemeriksaan HBsAg tahun 2018. Lembar 
data tersebut merupakan hasil pemeriksaan HBsAg secara rutin pada ibu hamil. Variabel independen yang diidentifikasi 
adalah  data karakteristik dan sosiodemografi. Uji Statistik deskriptif dilakukan berupa frekuensi, persentase. Hasil:  
Jumlah ibu hamil yang  reaktif  HBsAg  adalah 13 (2%) dari  647 ibu hamil sepanjang tahun 2018, diantara yang reaktif 
berada di usia 20-30 tahun. Namun Ibu hamil yang reaktif HBsAg sekitar   usia 20-30 tahun. Kesimpulan: Prevalensi 
HBsAg reaktif ibu Hamil di Wilayah Kerja Puskesmas  Binanga adalah  13(2%).  
 





Hepatitis B virus is a virus that can cause 
acute and chronic liver infections. For the 
most part, this virus is transmitted by the 
mother-to-child route.1  Chronic Hepatitis B 
virus (HBV) infection (Chronic Hepatitis 
B/CHB) is a global health problem. It is 
estimated that around 240 million people are 
infected worldwide, which can lead to the risk 
of liver disease and hepatocellular carcinoma 
(HCC). In HBV endemic areas, vertical or 
mother-to-child transmission becomes an 
important problem in the spread of 
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infection.2,3 Hepatitis B virus (HBV) infection 
can cause acute or chronic Hepatitis. Previous 
HBV infections were much more common but 
there are still 240 million chronic HBV 
carriers today and approximately 620,000 die 
per year from late sequelae of liver cirrhosis 
or hepatocellular carcinoma.2,3,5 
Hepatitis B virus (HBV) is acquired through 
exposure to contaminated blood products, 
sexual activity or perinatal transmission. 
Although the prevalence of HBV is relatively 
low in the US (0.4%), with approximately one 
million Americans chronically infected by 
HBV, the prevalence is higher in East Asia 
(8%), (China 2 -18%, Taiwan 2-19%) and 
Hong Kong 4-10%, Southeast Asia (> 6%)  
(Thailand 1-25% and India 1- 66%, and sub-
Saharan Africa (8-12%). Since 1990 in 
America Both Tropical Latin and Central 
Latin America have seen a decline in the 
prevalence of HBV (to 1.6% in 2005), 
Indonesia 2-9%..4,6  The 3.5 million patients 
with chronic Hepatitis B worldwide, 600,000 
die from the associated disease each year. In 
Korea, the positive rate of Hepatitis B surface 
antigen (HBsAg) was high up to 10% in the 
1980s.After the introduction of HBV 
vaccination in 1983, it decreased significantly 
to 3% in 2008.7   Serological results show that 
the proportion of HBsAg positive in the 
Indonesian population is over the age of 1 
year is 7.1% A higher proportion was found in 
the adult population hope than children.8 
Several studies have shown that there is an 
increased risk of preterm delivery (odds ratio 
1.4; 11.5% vs 7.9%, P < 0.001), low birth 
weight (< 2500 g) (odds ratio 1.39; 10.4% vs 
7.8%, P = 0.009), premature rupture of 
membranes (8.9% vs 6.9%, P = 0.026), 
gestational diabetes (13.2% vs 8.8%, P < 
0.02) and congenital abnormalities (odds ratio 
1.55; 7.2% vs. 5.1%, P = 0.01) in pregnancy 
associated with HBV infection.6 Miscarriage,9  
liver damage,10   Acute or chronic hepatitis, 
cirrhosis of the liver, and hepatocellular 
carcinoma are the result of potentially life-
threatening infections, and are a major global 
health problem.11 
Diagnosis of chronic HBV infection is made 
by detecting Hepatitis B surface antigen 
(HBsAg) in serum for more than 6 months.6 
Preterm labor may increase if acute Hepatitis 
B is detected in the last trimester. Mother-to-
child transmission occurs in more than 60% of 
pregnancies associated with acute HBV 
infection at or near term.6 
Based on these facts, observations were made 
on examination data or HBsAg test results in 
pregnant women, with the aim of knowing the 
prevalence of HBsAg   reactive pregnant 
women at the Binanga Health Center, 
Mamuju Regency. The results of the study can 
be used as information in handling pregnant 
women and providing preventive measures for 
transmission.  
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MATERIAL AND METHOD 
This research is descriptive observational, 
by observing the HBsAg examination/ 
screening data sheet at the Binanga Health 
Center. Existing data was processed using 
SPSS version 20. The study was conducted in 
August 2021, by collecting data only on the 
2018 HBsAg examination sheet. The data 
sheet is the result of routine checks on 
pregnant women who visit the Binanga Health 
Center and “Posyandu”/health services in the 
Work Area. Binanga Health Center. HBsAg 
examination uses a rapid test by examining 
blood specimens. The main outcome 
(dependent variable) in this study was HBsAg 
status, which was coded 1 = 'reactive' and 0 = 
'non-reactive'. The independent variables 
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identified were age, educational status, 
employment status, type of work, education 
level, gravida, parturition, abortion, gestational 
age and having lived at home with hepatitis 
sufferers. Descriptive statistics are calculated 
using frequency, percentage 
 
RESULT AND DISCUSSION 
The number of pregnant women who 
have been tested for HBsAg rapid tests is 647 
throughout 2018. Some of the backgrounds of 
pregnant women participants such as 
characteristics, socio-demography and 
reactive and unreactive HBsAg are as shown 
in Table 1.  
Tabel 1.  Karakteristik partisipan ibu  hamil 




  <15 2 0.3 
15-24 219 33.8 
25-34 341 52.6 
35-44 83 12.8 
>45 2 0.3 
Level of education 
  Primary school 138 21.3 
Junior high school 83 12.8 
high school 247 38.2 
College 179 27.7 
Job status 
  Yes 272 42 
No 375 58 
Type of work 
  Civil servant 34 5.3 
Private 73 11.3 
Trader 7 1.1 
Other 533 82.3 
Gravida 
  1 207 32 
2-3 298 46 
4-5 108 16.7 
5> 34 5.3 
Parturition 
  0 234 36.2 
1 184 28.4 
2-3 189 29.2 
4-5 34 5.3 
>6 6 0.9 
Abortion 
  0 542 83.7 
1 78 12.1 
2 25 3.9 
3 2 0.3 
Gestational age (weeks) 
 <14 160 24.7 
14-27 273 42.2 
>27 214 33.1 
Have you ever lived with 
someone with Hepatitis? 
  Ya 3 0.5 
Tdk 644 99.4 
Examination of HBsAg on 647 pregnant 
women obtained 13 (2%) who were reactive 
or declared positive for HBsAg, can be seen 
in Table 2.  
Tabel 2. Hasil pemeriksaan HBsAg 
  Frequency  Percent (%) 
Not Reactive 634 98 
Reactive 13 2 
 
In Table 3. it can be seen that the age of 
pregnant women who are HBsAg reactive is 
dominated by the age of 25-34 years, namely 
7 (1%) and age 35-44 years at 4 (0.6%).  
 
Tabel  3. Hasil Pemeriksaan HBsAg pada 
berbagai usia 
Age 
HBsAg Examination Results N=647 
Not Reactive (%) Reactive(%) 
     
<15 2 (0.3) 0 (0) 
15-24 217 (33.5) 2 (0.3) 
25-34 334 (51.6) 7 (1) 
35-44 79 (12.2) 4 (0.6) 
>45 2 (0.3) 0 (0) 
 
Screening Hepatitis B by Rapid test, the 
specimen to be examined is blood. This 
Hepatitis B examination is a work program of 
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the Mamuju Health Office to detect pregnant 
women for Hepatitis B infection. The 
examination is carried out on pregnant women 
who visit the “Posyandu”/health services in 
the work area of the Community Health 
Center and pregnant women who visit the 
Community Health Center.  
A reactive/positive HBsAg examination 
indicates the presence of Hepatitis B infection 
in the body. The results of the examination of 
HBsAg in the blood of pregnant women, 
obtained 13 (2%) of 647 pregnant women 
who were declared reactive. This result is 
smaller than the prevalence data for Hepatitis 
B surface antigen (HBsAg) in Indonesia in 
2013 which was 7.1%, also compared to the 
prevalence data in Indonesia in 2007 which 
was 9.4%.12 compared to other studies on the 
African continent, there were 10.9 % of 422 
respondents who were examined for Hepatitis 
B surface antigen.1 Based on research by 
Girawan D, Judistiani of 196 subjects with 12 
(6.1%) of whom were HBsAg positive.13 
Reactive HBsAg can potentially cause 
infection during pregnancy which will have an 
impact on fetal development including 
development, placental function, fetal growth 
restriction.14 In addition, a positive HBsAg 
pregnancy can lead to a higher risk for the 
mother such as intrahepatic cholestasis 
pregnancy, postpartum hemorrhage. In 
vaginal delivery, positive HBsAg has a risk of 
placental abruption.15 Pregnant women can 
undergo immunological transformation, in 
which the immune system is needed to 
enhance and support pregnancy and fetal 
growth.16  
There are 1-9% of infants born with HBV 
infection to HBV carrier mothers, although 
newborns receive HBIG and active HBV 
vaccine in the neonatal period. This suggests 
that vaccination of mothers during the 
antenatal period can be beneficial in reducing 
the rate of transmission in the womb.17 As 
prenatal HBV screening in Ontario and 
follow-up testing after a positive HBsAg test 
is still low, there is a potential for vertical 
HBV transmission. As a result, the number of 
children born positive for HBsAg.18 
The age group of HBsAg positive or 
reactive pregnant women, the highest obtained 
at the age of 25-34 years is 7(1%). However, 
reactive HBsAg was also found at the age of 
15-24 years and age 35-44 years. This shows 
that pregnant women range with the incidence 
of Hepatitis infection. Every age group has the 
potential to suffer from Hepatitis. Based on 
research by Al-Busaf S et al that there is a 
significant relationship between Hepatitis B 
virus (HBV) infection in the age group, and 
education level. However, socio-demographic 
characteristics did not affect HBV infection in 
pregnant women attending antenatal visits at 
Korle-Bu Ghana Teaching Hospital.19 Ages 
25-34 years were of working age, and the 
chances of getting pregnant in the next period 
would be greater. Routine antenatal screening 
of pregnant women and especially contact 
screening can reduce vertical and horizontal 
transmission of HBV.20  
The incidence of new Hepatitis B cases 
can still continue in the early childhood period, 
which may be rooted in the low coverage of 
Hepatitis B immunization, which has the 
potential for mother to child HBV 
transmission from HBsAg positive pregnant 
women. Another problem is the high rate of 
HBV infection among young adults due to the 
presence of hidden Hepatitis B.12 
Providing health education about 
Hepatitis B virus transmission, the benefits of 
vaccination, and routine screening for all 
pregnant women are very useful for virus 
prevention.21  Screening or surveillance 
activities must be carried out to monitor the 
impact of progress on the Hepatitis B 
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reduction program such as the incidence of 
positive cases, deaths and services.22 
 
CONCLUSION 
Based on the research, it was found that there 
are still pregnant women in the working area 
of the Binanga Health Center in Mamuju 
Regency who are HBsAg reactive. 
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